Accounting for intensity variation in image analysis of large‐scale multiplexed clinical trial datasets
The Journal of Pathology: Clinical Research · 2023-11 · 9 (6) · 449-463
DOI: 10.1002/cjp2.342 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology: Clinical Research, online erschienen am 11.09.2023. Verfasst von Anja L Frei und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Cancer Research UK, Wellcome Trust.
Abstract (Originalsprache)
Multiplex immunofluorescence (mIF) imaging can provide comprehensive quantitative and spatial information for multiple immune markers for tumour immunoprofiling. However, application at scale to clinical trial samples sourced from multiple institutions is challenging due to pre‐analytical heterogeneity. This study reports an analytical approach to the largest multi‐parameter immunoprofiling study of clinical trial samples to date. We analysed 12,592 tissue microarray (TMA) spots from 3,545 colorectal cancers sourced from more than 240 institutions in two clinical trials (QUASAR 2 and SCOT) stained for CD4, CD8, CD20, CD68, FoxP3, pan‐cytokeratin, and DAPI by mIF. TMA slides were multi‐spectrally imaged and analysed by cell‐based and pixel‐based marker analysis. We developed an adaptive thresholding method to account for inter‐ and intra‐slide intensity variation in TMA analysis. Applying this method effectively ameliorated inter‐ and intra‐slide intensity variation improving the image analysis results compared with methods using a single global threshold. Correlation of CD8 data derived by our mIF analysis approach with single‐plex chromogenic immunohistochemistry CD8 data derived from subsequent sections indicates the validity of our method (Spearman's rank correlation coefficients ρ between 0.63 and 0.66, p ≪ 0.01) as compared with the current gold standard analysis approach. Evaluation of correlation between cell‐based and pixel‐based analysis results confirms equivalency ( ρ > 0.8, p ≪ 0.01, except for CD20 in the epithelial region) of both analytical approaches. These data suggest that our adaptive thresholding approach can enable analysis of mIF‐stained clinical trial TMA datasets by digital pathology at scale for precision immunoprofiling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Life Science Zurich Graduate School, PhD Program in Biomedicine, University of Zurich, Zurich, Switzerland.
- Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK.
- Southampton University Hospital NHS Foundation Trust, Southampton, UK.
- The Christie NHS Foundation Trust, Manchester, UK.
ORCID-Profile: Ritik Rak Sinha, Joanne Edwards, Owen J Sansom, David N Church, Viktor H Koelzer
Förderung
- Medical Research Council
- Cancer Research UK
- Wellcome Trust
- Cancerfonden
- Health Technology Assessment Programme
- NIHR Oxford Biomedical Research Centre
- Promedica Stiftung
- Roche
Zitieren
APA
Frei, A. L., McGuigan, A., Sinha, R. R., Glaire, M. A., Jabbar, F., Gneo, L., Tomasevic, T., Harkin, A., Iveson, T. J., Saunders, M., Oein, K., Maka, N., Pezella, F., Campo, L., Hay, J., Edwards, J., Sansom, O. J., Kelly, C., Tomlinson, I., …, & Koelzer, V. H. (2023). Accounting for intensity variation in image analysis of large‐scale multiplexed clinical trial datasets. The Journal of Pathology: Clinical Research, 9(6), 449-463. https://doi.org/10.1002/cjp2.342
Vancouver
Frei AL, McGuigan A, Sinha RR, Glaire MA, Jabbar F, Gneo L, et al. Accounting for intensity variation in image analysis of large‐scale multiplexed clinical trial datasets. The Journal of Pathology: Clinical Research. 2023;9(6):449-463. doi:10.1002/cjp2.342
BibTeX
@article{Frei2023,
author = {Frei, Anja L and McGuigan, Anthony and Sinha, Ritik Rak and Glaire, Mark A and Jabbar, Faiz and Gneo, Luciana and Tomasevic, Tijana and Harkin, Andrea and Iveson, Tim J and Saunders, Mark and Oein, Karin and Maka, Noori and Pezella, Francesco and Campo, Leticia and Hay, Jennifer and Edwards, Joanne and Sansom, Owen J and Kelly, Caroline and Tomlinson, Ian and Kildal, Wanja and Kerr, Rachel S and Kerr, David J and Danielsen, Håvard E and Domingo, Enric and TransSCOT Consortium, TransSCOT Consortium and Church, David N and Koelzer, Viktor H},
title = {Accounting for intensity variation in image analysis of large‐scale multiplexed clinical trial datasets},
journal = {The Journal of Pathology: Clinical Research},
year = {2023},
volume = {9},
number = {6},
pages = {449--463},
doi = {10.1002/cjp2.342}
}
EUVIMED